VETERINARY TEAM REFERENCE

DEA & state schedules

Scheduling applies to the medication, not to the patient. This independent reference is not affiliated with the DEA.

Activated attapulgite combination (Endosorb)

FEDERAL STATUS

Not federally scheduled

The identified ingredients in this entry are not listed in the reviewed federal schedules. Prescription-only status, product restrictions and state law are separate questions.

Federal source ↗

State / prescribing or dispensing jurisdiction

STATE STATUS

Select a jurisdiction

Choose the state relevant to prescribing or dispensing. Patient residence alone may not determine every applicable rule.

What each federal schedule means

Highlighted rows match the verified federal or selected state schedule. The schedule describes legal control and abuse potential; it does not rank clinical usefulness or establish a dose.

Federal Schedules I–V: meaning and practice implications
Schedule	Meaning and practice
I	High abuse potential; no currently accepted medical use in U.S. treatment; lacks accepted safety under medical supervision. In practice: Not available for routine veterinary prescribing. Authorized research is a separate pathway.
II	High abuse potential; accepted medical use, sometimes with severe restrictions; abuse can cause severe dependence. In practice: No prescription refills under federal law. Strict prescribing, security and record requirements apply.
III	Less abuse potential than I or II; accepted medical use; abuse can cause moderate or low physical dependence or high psychological dependence. In practice: Federal prescriptions allow up to five authorized refills within six months. State rules may be stricter.
IV	Lower abuse potential than III; accepted medical use; limited dependence risk relative to III. In practice: The same federal five-refill / six-month prescription limit applies. Controlled-drug handling still applies.
V	Lower abuse potential than IV; accepted medical use; limited dependence risk relative to IV. In practice: Still controlled. Check authorized refills and state limits; do not automatically apply the III–IV refill rule.

What this means for the chart

For a controlled medication, confirm the prescriber’s authority for the applicable schedule, the exact formulation and quantity, authorized refills, secure handling, and required inventory / dispensing records. Check the state’s veterinary rules and any prescription monitoring program (PDMP) requirements or exemptions.

A PDMP reporting requirement does not by itself make a drug scheduled. “Not federally scheduled” does not mean over the counter, risk-free, or exempt from state law. States may use additional categories, such as Schedule VI, outside the federal I–V system.

← Medication & Supplement Reference

VETERINARY TEAM REFERENCE · SUPPLEMENT

Activated attapulgite combination (Endosorb)

A stool-consistency and gastrointestinal support product. The manufacturer describes an adsorbent/demulcent preparation and supplies a supplement-style FDA disclaimer; it should not be presented as an FDA-approved cure for diarrhea.

Adsorbent/demulcent gastrointestinal support combinationProduct-specific clinical reference

Updated October 16, 2026 · Sources and review status below

For veterinarians and veterinary staff. Product-label information is distinct from extra-label clinical practice. This is not a complete prescribing formulary or an automated interaction screen. Verify the current label, exact formulation, patient and species-specific clinical reference before use. Independent veterinary/pharmacy review remains pending.

Prescribing overview

Endosorb Tablets support stool consistency in dogs and cats; the manufacturer supplies a supplement disclaimer, not an FDA-approved drug indication.

Key prescribing checks

Persistent diarrhea, dehydration or deterioration requires investigation; improved stool consistency does not establish that the cause has resolved.
Check the full product label and veterinarian-directed plan before use, especially when other oral products are being given.

Uses by species

Approval and evidence apply to the named product, species, route and indication. An extra-label use requires its own prescribing assessment; a human indication is not an animal approval.

Dogs and cats

Support product; not an approved disease-treatment claim

Support for intestinal disturbances and nonspecific diarrhea

Improved stool appearance does not establish that the cause has resolved.

Use / indication source ↗

Pharmacology & pharmacokinetics

Mechanism and clinical role

Activated attapulgite with carob pulp, citrus pectin and magnesium trisilicate is described as an adsorbent/demulcent preparation.

Absorption, distribution, metabolism and elimination

Quantitative species-specific systemic pharmacokinetics were not established in the reviewed manufacturer information.

SAFETY REFERENCE · PRODUCT & SPECIES SPECIFIC

Contraindications & cautions

Contraindications identify circumstances where the source says a product should not be used. Precautions call for assessment or monitoring. Interactions identify combinations to review. They are distinct categories; this summary does not replace a full interaction check or the current product label.

Supplement safety information may be limited. A missing contraindication list does not establish safety in every species, during pregnancy, or with other treatments.

Endosorb Tablets

Manufacturer canine/feline tablet supplement information.

Contraindications · when not to use

The reviewed product page and specimen label do not supply a formal contraindication list.

Precautions & monitoring

Veterinary supervision and current-package precautions apply; specimen labeling may differ. Not for humans.

Do not interpret omitted contraindications or interactions as established safety.

Safety sources checked: October 16, 2026. Selected label information; independent veterinary or veterinary-pharmacy review remains pending. A label for dogs, cats, horses or humans does not establish safety for another species.

Adverse effects

The page does not provide a comprehensive adverse-reaction profile or interaction assessment.

These are selected source-reported effects, not incidence estimates or an exhaustive list. Spontaneous postmarketing reports do not by themselves establish frequency or causality.

Dosing & administration

Verify the source before prescribing. The regimens below summarize selected veterinary product labels, not every accepted veterinary use. They are not automatic substitutions between brands or formulations. Renal/hepatic disease, concurrent therapy, age, indication and clinical response can require a different plan.

No approved veterinary drug-dose regimen is established here for this supplement. Manufacturer serving directions are not equivalent to an evidence-based treatment protocol.

No FDA-approved drug regimen. Manufacturer administration guidance should be checked against the current tablet label and the veterinarian's plan; do not transfer it to suspension.

Extra-label prescribing and food-animal residue requirements are separate from labeled regimens. FDA extra-label-use guidance ↗

Drug & supplement interactions

This is a selected interaction reference, not an automated or comprehensive combination checker. Reconcile prescription drugs, nonprescription products, supplements and recent treatment changes.

Endosorb Tablets

Manufacturer canine/feline tablet supplement information.

Interactions are not established in the reviewed manufacturer information.

Interaction source ↗Interaction source ↗

Monitoring

Track stool, hydration, appetite and clinical course; persistent diarrhea or deterioration requires reassessment.

Client counseling

Use under veterinary supervision; disclose other oral medicines and seek care for worsening illness.

This section supports the veterinary team's discharge discussion; it does not replace the product’s Client Information Sheet where one is required.

Storage & handling

Store cool and dry, away from children; not for human use.

Brands, formulations & ingredient identity

Active ingredients

Activated attapulgite · Roasted powdered carob pulp · Citrus pectin · Magnesium trisilicate · Colloidal aluminum silicate (hydrated)

Other searchable names: attapulgite · palygorskite

Endosorb is a multi-ingredient product rather than a single generic drug.

This record covers tablets; suspension or other presentations require their own label comparison.

The manufacturer’s specimen label also lists hydrated colloidal aluminum silicate, artificial color and a base. Compare the current package, since specimen labeling may differ.

Shared ingredients do not establish interchangeable concentrations, routes, release properties, species labeling or regional availability.

Endosorb Tablets

Formulation: Oral support tablets
Label / product scope: Dogs · Cats

Support product with manufacturer FDA disclaimer; confirm full label.

Product label / source ↗

References & review status

Clinical reference updated October 16, 2026. Independent veterinary or veterinary-pharmacy review not yet completed. Evidence gaps remain explicitly identified; this page does not claim equivalence to a comprehensive, professionally reviewed veterinary formulary.

01PRN Pharmacal: Endosorb Tablets ↗02PRN Pharmacal: Endosorb Tablets specimen label ↗

Search another medication or supplement →

Prescribing overview

Key prescribing checks

Uses by species

Dogs and cats

Pharmacology & pharmacokinetics

Mechanism and clinical role

Absorption, distribution, metabolism and elimination

Contraindications & cautions

Contraindications · when not to use

Precautions & monitoring

Adverse effects

Dosing & administration

Drug & supplement interactions

Endosorb Tablets

Monitoring

Client counseling

Storage & handling

Brands, formulations & ingredient identity

Active ingredients

Endosorb Tablets

References & review status

Related Resources